Cardiac Implants LLC

Key People

• David Neumark - Inventor
• Nimrod Meller - Inventor
• David Alon - Inventor
• Bruce Modesitt - Inventor

Assessment

Team

Aspect: First-time physician innovator
Summary: The team comprises first-time physician innovators with expertise in cardiac device development.

While the team possesses strong medical and technical knowledge, their lack of prior entrepreneurial success in the MedTech sector could hinder effective commercialization and scaling of their innovations.

Clinical Need

Aspect: Strong
Summary: There is a strong clinical need for minimally invasive treatments for structural heart diseases.

The prevalence of structural heart diseases necessitates advanced treatment options. Cardiac Implants LLC's focus on percutaneous tricuspid and mitral valve annuloplasty devices aligns well with this need, offering less invasive alternatives to traditional surgical procedures.

Competition

Aspect: Very crowded + Strategics
Summary: The market for cardiac implant devices is highly competitive with numerous established players.

Major corporations like Abbott Laboratories, Medtronic, and Edwards Lifesciences dominate the cardiac implant market. Their established distribution channels, brand recognition, and financial resources create a challenging environment for new entrants like Cardiac Implants LLC.

Technical Challenge

Aspect: Complex
Summary: Developing minimally invasive cardiac devices involves significant technical complexities.

Creating devices such as percutaneous annuloplasty systems demands advanced engineering to ensure safety, efficacy, and compatibility with human anatomy. These technical challenges can extend development timelines and increase costs.

Patent

Aspect: Strong
Summary: The company holds a strong patent portfolio with multiple granted patents.

Cardiac Implants LLC has been granted several patents related to their cardiac devices, including innovations in anchor launchers and annuloplasty systems. This intellectual property can protect their technology from competitors and add value to the company.

Financing

Aspect: Medium
Summary: The company secured medium-level funding but faced financial challenges leading to closure.

Despite raising funds through venture capital, Cardiac Implants LLC struggled to secure the necessary capital to continue development and commercialization efforts, ultimately leading to the cessation of business activities.

Regulatory

Aspect: Pivotal Trial
Summary: The company initiated pivotal trials but did not complete them.

Cardiac Implants LLC began early feasibility studies for their devices but failed to report results within the required timeframe. This lack of compliance with regulatory timelines impeded progress toward obtaining necessary approvals for commercialization.

Opportunity Rollup

Odds of Success

3

Peak Market Share

4.15

Segment CAGR

15.1%

Market Segment

Cardiac Prosthetic Devices

Market Sub Segment

Transcatheter Heart Valves

Key Takeaway

Cardiac Implants LLC faced significant challenges in a competitive market, leading to its closure despite a strong patent portfolio and addressing a critical clinical need.